Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,355 | 355 | 100.0% |
| Education | $2.10 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,180 | 87 | $0 (2024) |
| Novo Nordisk Inc | $615.70 | 39 | $0 (2024) |
| PFIZER INC. | $482.37 | 36 | $0 (2024) |
| Lilly USA, LLC | $421.91 | 33 | $0 (2024) |
| Amgen Inc. | $363.14 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $301.68 | 15 | $0 (2024) |
| Bausch Health US, LLC | $240.06 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $215.00 | 16 | $0 (2024) |
| Exact Sciences Corporation | $183.78 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $141.27 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,977 | 125 | ABBVIE INC. ($397.77) |
| 2023 | $2,178 | 157 | ABBVIE INC. ($496.19) |
| 2022 | $945.82 | 58 | Novo Nordisk Inc ($256.56) |
| 2021 | $255.22 | 17 | Novo Nordisk Inc ($70.77) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: PAIN | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Education | In-kind items and services | $1.05 | General |
| Category: Neurology | ||||||
| 10/18/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: Cardio-renal | ||||||
| 09/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: PAIN | ||||||
| 09/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 229 | 292 | $59,413 | $17,550 |
| 2022 | 9 | 501 | 559 | $80,111 | $28,351 |
| 2021 | 5 | 355 | 394 | $49,646 | $20,195 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 137 | $33,291 | $9,487 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 93 | $15,996 | $4,281 | 26.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $4,960 | $2,030 | 40.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,116 | $1,246 | 30.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 15 | 15 | $930.00 | $474.12 | 51.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 15 | $120.00 | $33.00 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 321 | 376 | $53,717 | $18,777 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 53 | $11,116 | $3,564 | 32.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 26 | 26 | $5,906 | $2,704 | 45.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $4,830 | $1,952 | 40.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 23 | 23 | $2,466 | $701.08 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,254 | $462.27 | 36.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $481.00 | $89.64 | 18.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 22 | 23 | $230.00 | $69.20 | 30.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 15 | $111.00 | $31.37 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 219 | 250 | $34,250 | $14,220 | 41.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 62 | $12,524 | $4,968 | 39.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 18 | $1,476 | $643.32 | 43.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 27 | 28 | $1,036 | $252.28 | 24.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 34 | 36 | $360.00 | $110.95 | 30.8% |
About Tara Coyle
Tara Coyle is a Primary Care healthcare provider based in Shelbyville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2021. The National Provider Identifier (NPI) number assigned to this provider is 1720670342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tara Coyle has received a total of $5,357 in payments from pharmaceutical and medical device companies, with $1,977 received in 2024. These payments were reported across 357 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,355).
As a Medicare-enrolled provider, Coyle has provided services to 1,085 Medicare beneficiaries, totaling 1,245 services with total Medicare billing of $66,095. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Location Shelbyville, KY
- Active Since 02/04/2021
- Last Updated 02/04/2021
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1720670342
Products in Payments
- UBRELVY (Drug) $594.75
- VRAYLAR (Drug) $428.11
- Kerendia (Drug) $301.68
- MOUNJARO (Drug) $282.65
- Ozempic (Drug) $259.25
- APLENZIN (Drug) $223.21
- COMIRNATY (Biological) $187.39
- Cologuard Collection Kit (Device) $183.78
- NURTEC ODT (Drug) $182.74
- JARDIANCE (Drug) $153.11
- Otezla (Drug) $150.29
- ELIQUIS (Drug) $142.20
- TRINTELLIX (Drug) $125.45
- QULIPTA (Drug) $123.71
- YUPELRI (Drug) $117.60
- EVENITY (Biological) $116.52
- Wegovy (Drug) $110.59
- Rybelsus (Drug) $97.27
- TRELEGY ELLIPTA (Drug) $91.08
- Aimovig (Biological) $80.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Shelbyville
Mrs. Lori Dunnavant, Fnp-C, FNP-C
Primary Care — Payments: $1,292
Staci Smith, Fnp, FNP
Primary Care — Payments: $1,024
Ms. Tai Morrell, Np, NP
Primary Care — Payments: $910.68
Mr. Bryan Berry, Aprn, Fnp-Bc, Onp-C, APRN, FNP-BC, ONP-C
Primary Care — Payments: $735.69
Mrs. Megan Linville, Np, NP
Primary Care — Payments: $225.25